Relevant bibliographies by topics / Breast Cancer Worry

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Breast Cancer Worry'

Author: Grafiati
Published: 5 June 2025
Last updated: 24 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Breast Cancer Worry.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Breast Cancer Worry"

1

Lloyd, Kelly E., Louise H. Hall, Lucy Ziegler, and Samuel G. Smith. "Breast cancer worry in higher-risk women offered preventive therapy: a UK multicentre prospective study." Breast Cancer Research and Treatment 188, no. 3 (2021): 703–12. http://dx.doi.org/10.1007/s10549-021-06183-x.

Full text
Abstract:
Abstract Purpose Women’s worry about developing breast cancer may influence their decision to use preventive therapy. However, the direction of this relationship has been questioned. We prospectively investigated the relationship between breast cancer worry and uptake of preventive therapy. The socio-demographic and clinical factors associated with high breast cancer worry were also investigated. Methods Women at increased risk of developing breast cancer were recruited from clinics across England (n = 408). Participants completed a survey on their breast cancer worry, socio-demographic and clinical factors. Uptake of tamoxifen was recorded at 3 months (n = 258 women, 63.2%). Both primary and sensitivity analyses were conducted using different classifications of low, medium and high worry. Results 39.5% of respondents reported medium breast cancer worry at baseline and 21.2% reported high worry. Ethnic minority women were more likely to report high worry than white women (OR = 3.02, 95%CI 1.02, 8.91, p = 0.046). Women educated below degree level were more likely to report high worry than those with higher education (OR = 2.29, 95%CI 1.28, 4.09, p = 0.005). No statistically significant association was observed between worry and uptake. In the primary analysis, fewer respondents with medium worry at baseline initiated tamoxifen (low worry = 15.5%, medium = 13.5%, high = 15.7%). In the sensitivity analysis, participants with medium worry reported the highest uptake of tamoxifen (19.7%). Conclusions No association was observed between worry and uptake, although the relationship was affected by the categorisation of worry. Standardised reporting of the classification of worry is warranted to allow transparent comparisons across cohorts.
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Li Rita, Anna M. Chiarelli, Gord Glendon, et al. "Worry Is Good for Breast Cancer Screening: A Study of Female Relatives from the Ontario Site of the Breast Cancer Family Registry." Journal of Cancer Epidemiology 2012 (2012): 1–9. http://dx.doi.org/10.1155/2012/545062.

Full text
Abstract:
Background. Few prospective studies have examined associations between breast cancer worry and screening behaviours in women with elevated breast cancer risks based on family history.Methods. This study included 901 high familial risk women, aged 23–71 years, from the Ontario site of the Breast Cancer Family Registry. Self-reported breast screening behaviours at year-one followup were compared between women at low (N=305), medium (N=433), and high (N=163) levels of baseline breast cancer worry using logistic regression. Nonlinear relationships were assessed using likelihood ratio tests.Results. A significant non-linear inverted “U” relationship was observed between breast cancer worry and mammography screening (P=0.034) for all women, where women at either low or high worry levels were less likely than those at medium to have a screening mammogram. A similar significant non-linear inverted “U” relationship was also found among all women and women at low familial risk for worry and screening clinical breast examinations (CBEs).Conclusions. Medium levels of cancer worries predicted higher rates of screening mammography and CBE among high-risk women.
APA, Harvard, Vancouver, ISO, and other styles
3

Wallner, Lauren P., Nancy K. Janz, Yun Li, et al. "Worry about recurrence and patient preferences for provider roles in collaborative breast cancer care." Journal of Clinical Oncology 35, no. 8_suppl (2017): 158. http://dx.doi.org/10.1200/jco.2017.35.8_suppl.158.

Full text
Abstract:
158 Background: Prior studies have shown that worry about recurrence is a common problem during cancer treatment and survivorship and may be associated with symptom response and surveillance after primary treatment. However, whether worry about recurrence influences patient preferences for which provider to see for their continuing care remains unknown. Methods: A random sample of patients newly diagnosed with breast cancer in 2014-15 as reported to the Georgia and Los Angeles SEER registries were surveyed approximately 6 months after diagnosis (N = 2,502, 70% response rate). Frequency of worry about recurrence was defined by asking women to indicate on a 5-pt scale how often they worried about their cancer coming back in the past month (not at all-always) and was then dichotomized as frequent worry (sometimes/often/almost always) vs. less worry (almost never/rarely). Patient preferences for which provider manages certain aspects of care after treatment were ascertained for: follow-up mammograms, screening for other cancers, general preventive care, and treatment of comorbidities. Response categories included primary care clinician (PCP), cancer doctors, either or both. The associations between patient-reported worry about recurrence with preferences for provider roles were assessed using multinomial logistic regression. Results: In this sample, 37% of women reported worrying frequently about recurrence. Controlling for patient and clinical factors, women who reported more frequent worry (vs. less worry) were more likely to prefer to see both clinicians (vs. PCP only) for mammograms (OR: 2.3, 95%CI: 1.5, 3.6), screening for other cancers (OR: 2.3, 95%CI: 1.5, 3.5), general preventive care (OR: 1.6, 95%CI: 1.1, 2.3) and comorbidity care (OR: 1.5, 95%CI: 1.03, 2.2). Conclusions: Frequent worry about recurrence was common in this sample of women with favorable prognosis breast cancer. More frequent worry about breast cancer recurrence was associated with stronger preferences for seeing both PCPs and oncologists for continuing care after treatment. Assessing and managing worry about recurrence early in survivorship may improve collaborative cancer care and reduce duplicated services after treatment.
APA, Harvard, Vancouver, ISO, and other styles
4

Katz, Steven J., Kevin C. Ward, Ann S. Hamilton, Paul Abrahamse, Sarah T. Hawley, and Allison W. Kurian. "Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer." JCO Precision Oncology, no. 2 (November 2018): 1–8. http://dx.doi.org/10.1200/po.18.00225.

Full text
Abstract:
Background There are concerns that multigene panel testing compared with BRCA1/2-only testing after diagnosis of breast cancer may lead to unnecessary patient worry about cancer because of more ambiguous results. Methods Patients with breast cancer diagnosed from 2013 to 2015 and accrued from SEER registries in Georgia and Los Angeles were surveyed (n = 5,080; response rate, 70%), and responses were merged with SEER data and germline genetic testing and results. We examined patient reports of cancer worry by test type and results in 1,063 women who linked to a genetic test and reported undergoing testing. Results More than half of the sample (n = 640; 60.2%) received BRCA1/2-only testing versus 423 patients (39.8%) who had a multigene panel. A minority of tested patients reported substantial cancer worry after treatment: 11.1% (n = 130) reported higher impact of cancer worry, and 15.1% (n = 162) reported a high frequency of cancer worry (worrying often or almost always) in the past month. Impact of cancer worry did not substantively differ by test type, test result outcomes, or clinical or treatment factors. The odds ratio for higher impact of cancer worry was 0.81 (95% CI, 0.51 to 1.28) for multigene versus BRCA1/2-only testing. In a separate model, the odds ratios were 1.21 (95% CI, 0.54 to 2.68) and 0.90 (95% CI, 0.50 to 1.62) for pathogenic variant and variant of uncertain significance, respectively, versus a negative test (the reference group). Conclusion Compared with BRCA1/2 testing alone, multigene panel testing was not associated with increased cancer worry after diagnosis of breast cancer.
APA, Harvard, Vancouver, ISO, and other styles
5

Tewari, Apoorva, and Anees B. Chagpar. "Worry about Breast Cancer Recurrence: A Population-based Analysis." American Surgeon 80, no. 7 (2014): 640–45. http://dx.doi.org/10.1177/000313481408000716.

Full text
Abstract:
As more patients with breast cancer survive treatment, the importance of their long-term quality of life is increasing. One important concern for many survivors is fear of recurrence. To better understand worry about recurrence, we conducted a population-based statistical analysis. The National Health Interview Survey (NHIS) is the largest annual source of health information for the U.S. population. We obtained data from the 2010 survey, which asked breast cancer survivors about their fear of recurrence and quality of life. Data were analyzed using SUDAAN software. The 2010 NHIS sample represented 2,668,697 breast cancer survivors. On univariate analysis, worry about recurrence was correlated with current age ( P = 0.03) and radiation therapy ( P = 0.04). Worry was strongly associated with perceived risk of recurrence ( P < 0.01) and decreased overall quality of life ( P < 0.01) as well as lower self-reported physical ( P < 0.01) and mental ( P < 0.01) health and poor satisfaction with social activities and relationships ( P < 0.01). On multivariate analysis, worry was not independently associated with decreased quality of life ( P = 0.09). However, those who “always worried” about recurrence had a lower quality of life (odds ratio, 0.06; 95% confidence interval, 0.01 to 0.45). Worry about recurrence among breast cancer survivors is associated with age and radiation therapy and is correlated with self-reported physical health, mental health, social relationships, and overall quality of life. It is a significant predictor of decreased quality of life in those who worry the most. Screening for worry about recurrence is an important measure for the improvement of quality of life among breast cancer survivors.
APA, Harvard, Vancouver, ISO, and other styles
6

Artmann, A., M. Heyne, M. Kiechle, and N. Harbeck. "Breast self examination training and counseling as motivation strategies for breast awareness and participation in breast cancer screening programs." Journal of Clinical Oncology 24, no. 18_suppl (2006): 1027. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.1027.

Full text
Abstract:
1027 Background: In Germany, the particpation rate in gynecologic cancer and the Bavarian breast cancer screening program is only about 30%. Therefore, the impact of counseling and raising confidence in breast self examination (BSE) by a structured BSE training on breast awareness, acceptance of screening offer, and participation rate was evaluated. For evaluation of the training quality, specified MammaCare data sheets and questionnaires were used. Method: Since 2003, 167 women (mean age 35 y; range 19–65 y; 61% ≥40 y) got intensive breast cancer counceling and were professionally trained in MammaCare BSE; 41% had positive breast cancer family history. In their beginner’s course, trainees got general BSE information, covering breast anatomy, breast symptoms, breast cancer screening and therapy. Participants practised BSE, after training on tactually accurate silicone breast models with simulated lumps in order to discriminate normal nodularity from lumps. After 3 months, the supervision sessions included BSE evaluation and - again - professional instruction. In a model exam false positive and negative findings were documented. In breast exams, performance technique and breast tissue coverage were assessed. At both initial sessions and after 12 months, questionnaires on BSE practice, experience, and compliance, cancer worry, acceptance and participation at cancer screening programs were evaluated. Results: Breast cancer worry, anxiety, and lack of information were the main reasons for program participation. Within 3 months after the base course, mean decrease of breast cancer worry was about 95%. Participation in gynecologic and breast cancer screening (≥40 y) more than doubled (94% and 86%). Even after 12 months, these numbers remain consistent. 80% of participants practice BSE monthly, and 46% reported changes in lifestyle regarding nutrition and obesity. Conclusions: Our approach emphasizes importance of self confidence and awareness for participation in cancer screening, also in women with breast cancer family history. Counseling, BSE re-evaluation and reinforcement are correlated with decreased breast cancer worry, a main barrier against participation in breast and gynecologic cancer screening. [Table: see text]
APA, Harvard, Vancouver, ISO, and other styles
7

Kreizenbeck, Karma L., Kathryn Egan, Tracy Wong, et al. "Baseline cancer worry and tumor marker testing among earlier-stage breast cancer patients participating in a Choosing Wisely pilot." Journal of Clinical Oncology 38, no. 29_suppl (2020): 153. http://dx.doi.org/10.1200/jco.2020.38.29_suppl.153.

Full text
Abstract:
153 Background: We developed a patient-facing video aimed at raising early breast cancer survivors’ adherence to ASCO’s Choosing Wisely recommendation against surveillance tumor marker testing. To understand the impact of the video on cancer worry regarding recurrence, we surveyed breast cancer survivors before and after viewing the video. Methods: Women with stage I-IIIA breast cancer (N=246) treated at six regional community clinics were surveyed prior to viewing a video at the start of surveillance, then again at follow-up one year later (N=171). Both surveys included the Cancer Worry Scale (CWS-8 items, 4-point Likert scale). Tumor marker (TM) testing during surveillance was collected for 728 patients and linked to surveys among those who provided consent (N=105). Results: Most women (77%) were white age 50+. Among women who completed both questionnaires (N=153), the average CWS summary score was 17.1 at baseline (range=9-29) and 16.9 at follow-up ( p=0.48, range=8-30). Women who did not view the video (A) and those with high baseline cancer worry (B) who viewed the video had similar rates of TM testing (19%) compared to patients with low baseline cancer worry (C) who viewed the video (3%). Cancer worry is highly correlated with the decision to use of TM testing. Viewing an informational video that provided evidence-based advice on follow-up and testing did not impact cancer worry. Enrollment among eligible patients was impacted by challenges to proactively identify and consent patients during their transition to surveillance. Conclusions: Patients with high baseline cancer worry may need different or additional guidance beyond an educational video during their transition to surveillance for breast cancer. [Table: see text]
APA, Harvard, Vancouver, ISO, and other styles
8

Shumway, Dean Alden, Rebecca Leinberger, Kent A. Griffith, et al. "Management of worry about recurrence in breast cancer survivors." Journal of Clinical Oncology 31, no. 31_suppl (2013): 21. http://dx.doi.org/10.1200/jco.2013.31.31_suppl.21.

Full text
Abstract:
21 Background: Worry about recurrence is a significant concern for breast cancer survivors. We explored physicians‘ confidence and practices in identifying and managing worry. Methods: We surveyed a random sample of 1,500 surgeons and medical oncologists drawn from the AMA Masterfile in 2012. Physician responses to questions regarding their confidence were stratified by practice specialty and compared using the Wilcoxon rank-sum test. Correlates of use of each strategy for managing worry were modeled using multiple variable logistic regression. Results: 896 physicians (59.7%) responded: 498 surgeons and 398 medical oncologists, of whom 85.5% saw breast cancer patients. 62% reported initiating discussions regarding worry about recurrence. Overall, medical oncologists reported more confidence than surgeons in their ability to present risk information to patients, identify survivors with high levels of worry, and help patients manage their worry (p<0.001). Of note, 40.2% of physicians reported low levels of confidence managing worries surrounding recurrence. Confidence presenting risk information was significantly associated with treatment volume, which was highest with >50 cases/year. Surgeons who routinely followed breast cancer survivors for >3 years reported higher confidence; no such correlation existed among medical oncologists, but >90% of this group routinely followed patients for >3 yrs. Female physicians were significantly more likely to report being able to identify survivors with high levels of worry. Practice in an academic setting demonstrated associations with increased confidence. Use of worry management strategies varied by specialty. Medical oncologists were more likely to prescribe medication, address concerns in detail themselves, or refer to a psychologist or social worker. Longer follow-up was associated with increased likelihood of physicians addressing concerns themselves. Conclusions: A sizeable minority of physicians lack confidence in their ability to identify and manage worry in cancer survivors. Medical oncologists and surgeons differ significantly in their approach to worry management, suggesting that greater attention toward this issue in training and continuing education may be warranted.
APA, Harvard, Vancouver, ISO, and other styles
9

Lipkus, Isaac M., William M. P. Klein, Celette Sugg Skinner, and Barbara K. Rimer. "Breast cancer risk perceptions and breast cancer worry: what predicts what?" Journal of Risk Research 8, no. 5 (2005): 439–52. http://dx.doi.org/10.1080/1366987042000311018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

McCaul, KD, AB Canevello, JL Mathwig, and WMP Klein. "Risk communication and worry about breast cancer." Psychology, Health & Medicine 8, no. 4 (2003): 379–89. http://dx.doi.org/10.1080/13548500310001604513.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Breast Cancer Worry"

1

Yiu, Yui-tsi Dara, and 姚睿祉. "Worry over femininity loss and emotional reaction after hypothetical breast removal surgery." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B50700637.

Full text
Abstract:
Breast cancer patients consistently reported psychosocial adjustment difficulty in their sense of femininity after breast removal surgery. In view of this, the present study aimed to explore the effects of three femininity-related concepts on emotional reactions towards breast removal surgery – femininity schema, femininity loss appraisals, and femininity contingency of self-worth. 212 women without breast cancer history participated in this study. They completed a questionnaire which included a hypothetical scenario of breast removal. Results showed that women who considered the breast of a high relative importance in femininity schema, and depended their self-worth highly on sense of femininity, reported greater increase in negative emotions after hypothetical breast removal. This effect was mediated by femininity loss appraisals. Implications and future directions were discussed.<br>published_or_final_version<br>Clinical Psychology<br>Master<br>Master of Social Sciences
APA, Harvard, Vancouver, ISO, and other styles
2

Wade, Walsh Margo. "Women Receiving Genetic Counseling for Breast Cancer Risk: Cancer Worry, Psychological Distress, and Risk Recall Accuracy." Thesis, University of North Texas, 1999. https://digital.library.unt.edu/ark:/67531/metadc2185/.

Full text
Abstract:
This follows an earlier study of the same data set, which, through its findings, presented new questions that are investigated in this study. Both studies used a prospective controlled design, wherein women receiving genetic counseling for breast cancer risk were randomized into two groups. Subjects receiving an audiotaped recording of their genetic consultation (tape group) were compared to subjects who also had a genetic consultation but did not receive an audiotaped recording of it (no-tape group). Participants were drawn from attendees at the genetic clinics of two London hospitals and included 115 women with a family history of breast cancer. Cancer worry and psychological distress were assessed before genetic consultation (baseline), and at one- and six-month follow-ups by post. Objective risk was estimated by the geneticist during the consultation, and subjective risk was assessed at one month follow-up. The goals of the current study were to investigate relationships between cancer worry, psychological distress, and recall of genetic risk for breast cancer in a sample of women receiving genetic counseling for breast cancer risk, and to investigate the role sociodemographic variables on cancer worry, psychological distress, or risk recall for these women. Results for this sample of women with a family history of breast cancer found that there were consistent relationships between cancer worry, psychological distress, objective risk, and subjective risk before and after genetic consultation. This suggests that women=s psychological responses are appropriate to their level of cancer risk. There were no differences found between the tape and no-tape groups for objective or subjective risk, or for nearness of recall accuracy or degree of under-/over-estimation. Provision of an audiotaped recording of the genetic consultation did not appear to enhance recall of risk information. The role of sociodemographic variables on the psychological and risk variables assessed in this study was very minor. Age was mildly correlated with cancer worry, and employment was predictive of cancer worry only at baseline.
APA, Harvard, Vancouver, ISO, and other styles
3

Hughes, M. "The relationship between self-compassion and psychological distress in chronic physical health conditions : review of the literature and testing mediation by worry and rumination in breast cancer patients." Thesis, University of Liverpool, 2018. http://livrepository.liverpool.ac.uk/3026919/.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Breast Cancer Worry"

1

Publishing, Olzo. Worry Ends When the Faith Begins Breast Cancer Awareness: Unruled Composition Book. Independently Published, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Breast Cancer Worry"

1

Ashton, Kathleen, and Cheryl L. Thompson. "Did Cancer Kill My Sleep?" In Sleep Disorders. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780190671099.003.0048.

Full text
Abstract:
A two-time breast cancer survivor is troubled by worry of her cancer returning; along with poor sleep hygiene and lack of routine schedule, this leads to insomnia. After a negative polysomnogram, she is evaluated by a psychologist trained in sleep and integrated into the breast cancer clinic. Cognitive-behavioral therapy for insomnia is recommended. Insomnia is common among breast cancer patients and survivors and is likely due to a combination of factors, including anxiety over prognosis and treatment side effects, which are sometimes long-lasting. Treatment of insomnia in these patients has been shown to improve their quality of life. Short sleep duration and circadian rhythm disturbances are associated with cancer development, progression, and prognosis.
APA, Harvard, Vancouver, ISO, and other styles
2

Hadjikyriakou, Maria, and Maria Rueda-Lara. "Beneath the Surface: Uncovering Medical Causes of Anxiety." In Anxiety Disorders. Oxford University PressNew York, 2024. http://dx.doi.org/10.1093/med/9780197667859.003.0010.

Full text
Abstract:
Abstract This chapter introduces Ms. R, a 45-year-old woman who presents to the clinic with symptoms of rapid breathing, chest tightness, palpitations, shortness of breath, and an overwhelming fear of dying. She has been experiencing these symptoms intermittently for a week. She is undergoing treatment with tamoxifen for breast cancer, and her recent cancer diagnosis, treatment, and associated stress have contributed to her increasing worry. However, she has never experienced such attacks before. Her history of smoking and vital signs raises concerns for a possible underlying medical cause for her symptoms. This chapter emphasizes the importance of considering the broader clinical context when evaluating anxiety accompanied by physical symptoms. It discusses the concept of anxiety disorder due to another medical condition, where anxiety is a direct result of a medical disorder. Various therapeutic approaches are mentioned, emphasizing the need for individualized treatment plans tailored to the patient’s medical conditions and preferences.
APA, Harvard, Vancouver, ISO, and other styles
3

Russell, Cristine. "Risk Reporting." In A Field Guide for Science Writers. Oxford University Press, 2005. http://dx.doi.org/10.1093/oso/9780195174991.003.0044.

Full text
Abstract:
Over the past three decades, the media has bombarded the public with a seemingly endless array of risks, from the familiar to the exotic: hormone replacement therapy, anthrax, mad cow disease, SARS, West Nile virus, radon, vaccine-associated autism, childhood obesity, medical errors, secondhand smoke, lead, asbestos, even HIV in the porn industry. A drumbeat of risks to worry about, big and small, with new studies often contradicting earlier ones and creating further confusion. It's gotten so bad that some people feel like they're taking their lives in their hands just trying to order a meal at a restaurant. “Will it be the mad cow beef, the hormone chicken, or the mercury fish?” asks an imperious waiter in one of my favorite cartoons from the Washington Post. “Urn ... I think I'll go with the vegetarian dish,” the hesitant diner responds. “Pesticide or hepatitis?” the waiter asks. The diner, growing ever more fearful, asks for water. The waiter persists: “Point source, or agricultural runoff?” Perhaps it's time for the media to become part of the solution rather than continuing to be part of the problem. Ideally, science journalists could lead the way toward improved risk coverage that moves beyond case-by-case alarms—and easy hype—to a more consistent, balanced approach that puts the hazard du jour in broader perspective. The challenge is to create stories with chiaroscuro, painting in more subtle shades of gray rather than extremes of black and white. Too often, as my late Washington Post colleague Victor Cohn once said, journalists (and their editors) gravitate toward stories at either extreme, emphasizing either “no hope” or “new hope.” Unfortunately, today's “new hope” often becomes tomorrow's “no hope” (which is a good reason for avoiding words like “breakthrough” or “cure” in the first place). Hormone replacement therapy (HRT) is a classic example of this yo-yo coverage. In the '60s and '70s, the media helped overpromote hormones as wonder drugs for women, promising everlasting youth as well as a cure for hot flashes. Concerns rose, however, with reports of possible links to cancers of the breast and uterus. Later, when the uterine cancer risk was shown to return to normal by adding an additional hormone, the publicity about HRT became mostly positive again, emphasizing its potential to protect against bone loss and heart disease.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Breast Cancer Worry"

1

April-Sanders, Ayana K., and Parisa Tehranifar. "Abstract B54: Concordance between objective and perceived breast cancer risk and breast cancer worry in racially diverse and immigrant women." In Abstracts: Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 13-16, 2015; Atlanta, Georgia. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7755.disp15-b54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bradbury, Angela R., Linda Patrick-Miller, Brian Egleston, et al. "Abstract P6-10-17: Psychosocial adjustment, cancer worry and perceived risk in 6-13 year old girls from breast cancer families." In Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.sabcs14-p6-10-17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Arif, Tahera, and Mohammed Shamim Absar. "Abstract PS1-62: Two decades of experience with sentinel node staging of axilla - is false negative no longer a worry?" In Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.sabcs20-ps1-62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cimprich, B., DF Hayes, MK Askren, et al. "PD04-08: Altered Neurocognitive Responses Prior to Adjuvant Therapy for Breast Cancer: A Functional MRI Analysis of the Impact of Worry and Fatigue." In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-pd04-08.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Breast Cancer Worry' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography